Prosthetic Heart Valve Market by Type (Transcather, Tissue and Mechanical) Trends and Forecast, 2015 – 2021

Prosthetic Heart Valve Market by Type (Transcather, Tissue and Mechanical) Trends and Forecast, 2015 – 2021

Comments Off on Prosthetic Heart Valve Market by Type (Transcather, Tissue and Mechanical) Trends and Forecast, 2015 – 2021

According to the report, global prosthetic heart valve market was valued at USD 3,138.4 million in 2015, is expected to reach USD 5,302.1 million in 2021 and is anticipated to grow at a CAGR of 9.10% between 2016 and 2021.Heart valves play an important role in proper and one-directional blood flow. The heart consists of four main types of valves that are tricuspid, pulmonary, mitral, and aortic valves. Prosthetic heart valves are artificial valves implanted in the patients suffering from the valvular heart disorder. There are 3 types of prosthetic heart valve such as mechanical heart valve, tissue heart valve, and transcatheter heart valve. Previously, mechanical heart valves were used extensively, however, they lack anticoagulation property.




According to the report, global prosthetic heart valve market was valued at USD 3,138.4 million in 2015, is expected to reach USD 5,302.1 million in 2021 and is anticipated to grow at a CAGR of 9.10% between 2016 and 2021.

Prosthetic heart valve therapy is carried out for the patients suffering from the valvular heart disorder. Heart valve replacement was carried out in the early 1960s. It is reported that more than 60,000 patients undergo replacement surgery in U.S. every year and around 280,000 heart valve replacement cases worldwide. Prosthetic heart valve has 3 major types that are mechanical heart valve, tissue heart valve and transcatheter heart valve which is recently developed technique. Growing R&D for innovated techniques and introduction of new valves and valve replacement therapies foster the growth of prosthetic heart valve market.

The prosthetic heart valve market is primarily driven by factors such as rapid advancement in technology, rising occurrence of heart disorders and growth in aging population. Moreover, surging healthcare expenditure along with rising focus of major players on R&D for innovative products fuels the growth of the market. In addition, increasing awareness of heart valve replacement and availability of techniques for valve replacement stimulates the growth of the market. However, stringent regulations led by government mainly for use of tissue heart valve and the high cost of the surgery may impede the growth of prosthetic heart valve market. Nevertheless, the introduction of advance and minimally invasive techniques with high efficiency is likely to offer the ample opportunities for this market in the forecast period.

Global Prosthetic Heart Valves Market

There are mainly three types of a prosthetic heart valve that are transcatheter valves, tissue valve, and the mechanical valve. Tissue valve was considered to be the most prominent segment and gathered the highest share in 2015. Tissue valve is extracted from the pig and cow and treated for preventing rejection from the human body. Transcatheter heart valve is utilized to replace the damaged valve in the transcatheter aortic valve replacement (TAVR). In the TAVR, the damaged valve is repaired instead of replacing and is done with minimal invasion.

North America dominated the prosthetic heart valve market with the highest share in 2015. It is expected that the market in North America will gain traction in the forecast period owing to rising prevalence of heart valve disorders and increasing preference for minimal invasive practices. Moreover, surging demand for tissue heart valve replacement in U.S. will fuel the growth of the market in North America. Asia-Pacific is the fastest growing market for prosthetic heart valve due to rising disposable income along with escalating demand for valve replacement, particularly in India and China. Latin America is anticipated to experience sustainable growth in the coming years owing to unexploited market. The Middle East and Africa is estimated to grow at the moderate pace due to growing awareness and developing technologies.

Competition in the prosthetic heart valves market is intense and to stay competitive, companies are adopting strategies such as product innovation and inorganic growth. Some of the key players in the prosthetic heart valve market are Colibri Heart Valve, LLC, Cytograft Tissue Engineering, Inc. (CTE), Direct Flow Medical, Inc., Edwards Lifesciences LLC, Heart Leaflet Technologies (HLT), Perouse Medical, St. Jude Medical Inc.,and Sorin Group.

Other prominent participants in the market include Symetis, Transcatheter Technologies Gmbh, On-X Life Technologies, Inc., Neovasc Inc., Micro Interventional Devices, Inc, Leman Cardiovascular, JenaValve Technology, Boston Scientific Corporation, Claret Medical, Inc., Medtronic, Inc., TTK Healthcare and Braile Biomédica among others.

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global market revenue, 2015 – 2021(USD Million)
    • 2.2. Global prosthetic heart valve market: Snapshot
  • Chapter 3. Prosthetic Heart Valve Market – Global and Industry Analysis
    • 3.1. Prosthetic heart valve: Market dynamics
    • 3.2. Market drivers
      • 3.2.1. Drivers of global prosthetic heart valve market: Impact analysis
      • 3.2.2. Increasing prevalence of heart disorders
    • 3.3. Market restraints
      • 3.3.1. Restraints of global prosthetic heart valve market: Impact analysis
      • 3.3.2. High cost of the therapy
    • 3.4. Opportunities
      • 3.4.1. Increasing demand from the emerging economies
      • 3.4.2. Introduction of new techniques
    • 3.5. Porter’s five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by type segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Prosthetic Heart Valve Market – Competitive Landscape
    • 4.1. Company market share, 2014
      • 4.1.1. Global prosthetic heart valve market : company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Product Portfolio
    • 4.4. Patent Analysis (2011-2016)
      • 4.4.1. Patent Trend
      • 4.4.2. Patent Share by company
      • 4.4.3. By Region
  • Chapter 5. Global Prosthetic Heart Valve Market – Type Segment Analysis
      • 5.1. Global prosthetic heart valve market: type overview
    • 5.1.1. Global prosthetic heart valve market revenue share, by type, 2015 – 2021
    • 5.2. Transcather valve
      • 5.2.1. Global prosthetic heart valve market, by transcather valve, 2015 – 2021(USD Million)
    • 5.3. Tissue valve
      • 5.3.1. Global prosthetic heart valve market, by tissue valve, 2015 – 2021(USD Million)
    • 5.4. Mechanical valve
      • 5.4.1. Global prosthetic heart valve market, by mechanical valve, 2015 – 2021(USD Million)
  • Chapter 6. Global Prosthetic Heart Valve market – Regional Segment Analysis
    • 6.1. Global prosthetic heart valve market: Regional overview
      • 6.1.1. Global prosthetic heart valve market revenue share by region, 2015 – 2021
    • 6.2. North America
      • 6.2.1. North America prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
    • 6.3. Europe
      • 6.3.1. Europe prosthetic heart valve market revenue, by a type, 2015 – 2021(USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.3.3. France
        • 6.3.3.1. France prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.3.4. UK
        • 6.3.4.1. UK prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.4.2. China
        • 6.4.2.1. China prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.4.4. India
        • 6.4.4.1. India prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
    • 6.6. Middle East and Africa
      • 6.6.1. Middle East and Africa prosthetic heart valve market revenue, by type, 2015 – 2021(USD Million)
  • Chapter 7. Company Profile
    • 7.1. Colibri Heart Valve, LLC
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. Cytograft Tissue Engineering, Inc. (CTE)
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Direct Flow Medical, Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Edwards Lifesciences LLC
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Heart Leaflet Technologies (HLT)
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Perouse Medical
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. St. Jude Medical Inc.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. Sorin Group
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments
    • 7.9. Symetis
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments
    • 7.10. Transcatheter Technologies Gmbh
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product portfolio
      • 7.10.4. Business strategy
      • 7.10.5. Recent developments
    • 7.11. On-X Life Technologies, Inc.
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product portfolio
      • 7.11.4. Business strategy
      • 7.11.5. Recent developments
    • 7.12. Neovasc Inc.
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product portfolio
      • 7.12.4. Business strategy
      • 7.12.5. Recent developments
    • 7.13. Micro Interventional Devices, Inc
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product portfolio
      • 7.13.4. Business strategy
      • 7.13.5. Recent developments
    • 7.14. Leman Cardiovascular
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product portfolio
      • 7.14.4. Business strategy
      • 7.14.5. Recent developments
    • 7.15. JenaValve Technology
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Product portfolio
      • 7.15.4. Business strategy
      • 7.15.5. Recent developments
    • 7.16. Boston Scientific Corporation
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Product portfolio
      • 7.16.4. Business strategy
      • 7.16.5. Recent developments
    • 7.17. Claret Medical, Inc.
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Product portfolio
      • 7.17.4. Business strategy
      • 7.17.5. Recent developments
    • 7.18. Medtronic, Inc.
      • 7.18.1. Overview
      • 7.18.2. Financials
      • 7.18.3. Product portfolio
      • 7.18.4. Business strategy
      • 7.18.5. Recent developments
    • 7.19. TTK Healthcare
      • 7.19.1. Overview
      • 7.19.2. Financials
      • 7.19.3. Product portfolio
      • 7.19.4. Business strategy
      • 7.19.5. Recent developments
    • 7.20. Braile Biomédica
      • 7.20.1. Overview
      • 7.20.2. Financials
      • 7.20.3. Product portfolio
      • 7.20.4. Business strategy
      • 7.20.5. Recent developments
  • Chapter 8. Patents
    • 8.1. U.S. (US Patents)
    • 8.2. Europe (EP documents)
    • 8.3. Japan (Abstracts of Japan)
    • 8.4. Global (WIPO (PCT))

List of Figures

1. Prosthetic heart valve market segmentation
2. Global prosthetic heart valve market revenue, 2015  – 2021(USD Million)
3. Prosthetic heart valve: Market attractiveness analysis, by type segment
4. Prosthetic heart valve: Market attractiveness analysis, by regional segment
5. Global Prosthetic heart valve Market : Company Market Share, 2015
6. Patent trend between 2011 -2016
7. Patent Share by Company between 2011 – 2016
8. Patent Share by Region between 2011 – 2016
9. Global prosthetic heart valve market revenue share by type, 2015  – 2021
10. Global prosthetic heart valve market, by transcather valve, 2015  – 2021
11. Global prosthetic heart valve market, by tissue valve, 2015  – 2021
12. Global prosthetic heart valve market, by mechanical valve, 2015  – 2021
13. Global prosthetic heart valve market revenue share by region, 2015  – 2021


List of Tables

1. Global prosthetic heart valve market estimates and forecast, 2015  – 2021(USD Million)
2. Global prosthetic heart valve market, by region, 2015  – 2021(USD Million)
3. Global prosthetic heart valve market, by type, 2015  – 2021(USD Million)
4. Prosthetic heart valve – Key market driver analysis
5. Prosthetic heart valve – Key market restraint analysis
6. North America prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
7. U.S. prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
8. Europe prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
9. Germany prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
10. France prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
11. UK prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
12. Asia Pacific prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
13. China prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
14. Japan prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
15. India prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
16. Latin America prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
17. Brazil prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)
18. Middle East and Africa prosthetic heart valve market revenue, by type, 2015  – 2021(USD Million)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account